TOPICAL DELIVERY OF PUERARIN USING NANOSTRUCTURED LIPID CARRIER GEL: FORMULATION, CHARACTERIZATION, AND IN VITRO ASSESSMENT
DOI:
https://doi.org/10.22159/ajpcr.2025v18i9.55057Keywords:
Puerarin, Nanostructured lipid carrier, Topical gel, Nanoparticle.Abstract
Objectives: Puerarin is one of the oldest and most significant edible crude herbs in traditional Oriental medicine and is used as a muscle relaxant, antipyretic, anti-inflammatory, and antidysentery, as well as in the treatment of cardiovascular diseases. Puerarin topical gel based on nanostructured lipid carriers (NLCs) was developed to treat inflammation. This research will focus on preparing and evaluating transdermal drug delivery system formulations using appropriate excipients. Furthermore, NLCs will be incorporated into a transdermal gel to achieve specific delivery. Finally, the performance and efficacy of the optimized transdermal gel containing puerarin-loaded NLC will be thoroughly evaluated.
Methods: Propylene glycol served as a co-surfactant, Tween 20 as a surfactant, oleic acid as a liquid lipid, and stearic acid as a solid lipid made up of NLC. Particle size, differential scanning calorimetry, scanning electron microscopy, and Fourier transform infrared spectroscopy were used to characterize the NLCs using solvent emulsification procedures.
Results: The NLC exhibited impressive entrapment efficiency across all formulations, ranging from 45.90% to 87.80%. Formulation F1 emerged as the optimal NLC composition with an average particle size of 61.70 nm and a polydispersity index of 0.345, indicating a homogeneous particle size distribution. The stability of Formulation F1 was further confirmed by its high-magnitude zeta potential of −13.0 mV. Subsequently, Formulation F6 of the puerarin-loaded NLC gel underwent successful gelling and was evaluated for various parameters which demonstrated optimum results, suggesting the suitability of the nanoparticulate dispersion for further development.
Conclusion: The puerarin NLC gel exhibits potential for extended medication availability in skin tissues and may be applied more effectively to treat inflammatory diseases.
Downloads
References
1. Alhussein AB, Gaaz TS, Jaaz AH, Alsultany FH, Kadhum AA, Al-Amiery AA, et al. Preparation of nanoparticles loaded by dimethyl fumarate and their physical and chemical properties study. Adv J Chem Sect A. 2025;8(1):194-208. doi: 10.48309/ajca.2025.457575.1529
2. Phalak SD, Bodke V, Yadav R, Pandav S, Ranaware M. A systematic review on nano drug delivery system: Solid lipid nanoparticles (SLN). Int J Curr Pharm Res. 2024;16(1):10-20. doi: 10.22159/ ijcpr.2024v16i1.4020
3. Hassan DH, Shohdy JN, El-Nabarawi MA, El-Setouhy DA, Abdellatif MM. Nanostructured lipid carriers for transdermal drug delivery. Int J Appl Pharm. 2022;14(4):88-93. doi: 10.22159/ ijap.2022v14i4.44564
4. Jaiswal PK, Keserwani S, Chakrabarty T. Lipid-polymer hybrid nanocarriers as a novel drug delivery platform. Int J Pharm Pharm Sci. 2022;14(4):1-12. doi: 10.22159/ijpps.2022v14i4.44038
5. Crossen SL, Goswami T. Nanoparticulate carriers for drug delivery. J Pharm Biopharm Res. 2022;4(1):237-47. doi: 10.25082/ JPBR.2022.01.001
6. Sathyanarayana T, Sudheer P, Jacob E, Sabu MM. Development and evaluation of nanostructured lipid carriers for transdermal delivery of ketoprofen. Fabad J Pharm Sci. 2022;48(1):105-24. doi: 10.55262/ fabadeczacilik.1126288
7. Jahnavi P, Krishnan K, Rajashakar V, Burle GS, Reddy KT, Yeruva BM, et al. Organometallic nanoparticulate properties, and applications delivery: Synthesis. J Appl Organomet Chem. 2025;2(1):123-48.
8. Vegada R, Seth AK, Sachin C, Parikh P, Chainesh S, Vinod R. Formulation and evaluation of novel gum based drug delivery system of an antiemetic drug. Int J Pharm Res Technol. 2019;2(1):16-20. doi: 10.31838/ijprt/02.01.03
9. Nagaich U, Gulati N. Nanostructured lipid carriers (NLC) basedcontrolled release topical gel of clobetasol propionate: Design and in vivo characterization. Drug Deliv Transl Res. 2016;6(3):289-98. doi: 10.1007/s13346-016-0291-1, PMID: 27072979
10. Khurana S, Jain NK, Bedi PM. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam. Life Sci. 2013;93(21):763-72. doi: 10.1016/j.lfs.2013.09.027, PMID: 24113071
11. Vattikundala P, Chaudhary S, Sumithra M. Design, preparation, characterization, and evaluation of NR4A1 agonist novel 6-mercaptopurine monohydrate loaded nanostructured lipid carriers suspension for enhanced solubility and in vivo bioavailability. J Med Pharm Chem Res. 2025;7(6):1059-78. doi: 10.48309/ jmpcr.2025.472478.1381
12. Abass AM, Abdoon FM. Synthesis, characterization, and applications of metal oxides of ZnO, CuO, and CeO2 nanoparticles: A review. J Appl Organomet Chem. 2024;4(4):349-66. doi: 10.48309/ jaoc.2024.471305.1220
13. Arjun UV, Vidiyala N, Sunkishala P, Vidiyala P, Reddy KT, Elumalai S, et al. Bio-inspired green synthesis of nanoparticles for psoriasis treatment: A review of current status and future directions. Asian J Green Chem. 2025;9:373-403. doi: 10.48309/AJGC.2025.503808.1680
14. Khurana S, Jain NK, Bedi PM. Nanostructured lipid carriers based nanogel for meloxicam delivery: Mechanistic, in-vivo and stability evaluation. Drug Dev Ind Pharm. 2015;41(8):1368-75. doi: 10.3109/03639045.2014.950586, PMID: 25151872
15. Viegas C, Patrício AB, Prata JM, Nadhman A, Chintamaneni PK, Fonte P. Solid lipid nanoparticles vs. nanostructured lipid carriers: A comparative review. Pharmaceutics. 2023;15(6):1593. doi: 10.3390/ pharmaceutics15061593, PMID: 37376042
16. Sethuraman N, Shanmuganathan S, Sandhya K, Anbarasan B. Design, Development and Characterization of Nano Structured Lipid Carrier for Topical Delivery of Aceclofenac. Indian Journal of Pharmaceutical Education and Research. 2018;52(4):581-586. doi: 10.5530/ ijper.52.4.67
17. Praveen S, Gowda DV, Srivastava A, Osmani RA. Formulation and evaluation of nanostructured lipid carrier (NLC) for glimepiride. Pharm Lett. 2016;8(6):304-9.
18. Kharwade RS, Mahajan NM. Formulation and evaluation of nanostructured lipid carriers based anti-inflammatory gel for topical drug delivery system. Asian J Pharm Clin Res. 2019;12:286-91. doi: 10.22159/ajpcr.2019.v12i4.32000
19. Chaturvedi KA, Sara UV, Gupta RD. Design and optimization of Rifaximin macroparticles for colon targeting. J Res Pharm. 2024;28(5):1609-18. doi: 10.29228/jrp.838
20. Jin SE, Son YK, Min BS, Jung HA, Choi JS. Anti-inflammatory and antioxidant activities of constituents isolated from Pueraria lobata roots. Arch Pharm Res. 2012;35(5):823-37. doi: 10.1007/s12272-012- 0508-x, PMID: 22644850
21. Reddy MR, Gubbiyappa KS. A comprehensive review on supersaturable self-nanoemulsifying drug delivery system. Asian J Pharm Clin Res. 2021;14:40-4. doi: 10.22159/ajpcr.2021.v14i8.41987
22. Morakul B. Self-nanoemulsifying drug delivery systems (SNEDDS): An advancement technology for oral drug delivery. Pharm Sci Asia. 2020;47(3):205-20. doi: 10.29090/psa.2020.03.019.0121
23. Kok LY, Bannigan P, Sanaee F, Evans JC, Dunne M, Regenold M, et al. Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol. Eur J Pharm Sci. 2022;168:106058. doi: 10.1016/j.ejps.2021.106058, PMID: 34763088
24. Gao S, Tian B, Han J, Zhang J, Shi Y, Lv Q, et al. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. Int J Nanomedicine. 2019;14:6135-50. doi: 10.2147/IJN. S205295, PMID: 31447556
25. Chettupalli AK, Kakkerla A, Jadi RK, Uppu P, Ghazwani M, Hani U, et al. Design, development, and preclinical evaluation of pirfenidone-loaded nanostructured lipid carriers for pulmonary delivery. Sci Rep. 2025;15:11390.
26. Rao GK, Jamadar S. Development and characterization of asenapine maleate loaded nanostructured lipid carrier for improved brain delivery. J Dispers Sci Technol. 2025;1-14. doi: 10.1080/01932691.2025.2483902
27. Chen P, Zhang H, Cheng S, Zhai G, Shen C. Development of curcumin loaded nanostructured lipid carrier based thermosensitive in situ gel for dermal delivery. Colloids Surf A Physicochem Eng Aspects. 2016;506:356-62. doi: 10.1016/j.colsurfa.2016.06.054
28. Gautam D, Chaurasia H, Singh R. Design and optimization of lomefloxacin loaded NLC gel for ophthalmic drug delivery. Int J Health Sci (Qassim). 2022;6:7022-44. doi: 10.53730/ijhs.v6nS3.7637
29. Ahmad A, Ayub H. Fourier transform infrared spectroscopy (FTIR) technique for food analysis and authentication. In: Pathare PB, Rahman MS, editors. Nondestructive Quality Assessment Techniques for Fresh Fruits and Vegetables. Singapore: Springer Nature Singapore; 2022. p. 103-42. doi: 10.1007/978-981-19-5422-1_6
30. Sethuraman N, Shanmuganathan S, Sandhya K, Anbarasan B. Design, development and characterization of nano structured lipid carrier for topical delivery of aceclofenac. Indian J Pharm Educ Res. 2018;52(4):581-6. doi: 10.5530/ijper.52.4.67
31. Baraga WM, Shtewia FA, Ulsalam Tarrousha AA, Al-Adiwisha WM, Altounsib MK. Green synthesis of silver nanowires using aqueous Brassica tournefortii leaves extract and evaluation of their antibacterial and antioxidant activities. J Appl Organomet Chem. 2025;5(1):13-27. doi: 10.48309/jaoc.2025.485302.1244
32. Bhange MA, Pethe A, Hadke A. Design and development of phytosomal soft nanoparticles for liver targeting. Int J Appl Pharm. 2023;15(1):280-9. doi: 10.22159/ijap.2023v15i1.46303
33. Mendes IT, Ruela AL, Carvalho FC, Freitas JT, Bonfilio R, Pereira GR. Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil. Colloids Surf B Biointerfaces. 2019;177:274-81. doi: 10.1016/j. colsurfb.2019.02.007, PMID: 30763792
34. Garg NK, Tandel N, Bhadada SK, Tyagi RK. Nanostructured lipid carrier-mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases. Front Pharmacol. 2021;12:713616. doi: 10.3389/fphar.2021.713616, PMID: 34616297
35. Garg NK, Tandel N, Bhadada SK, Tyagi RK. Corrigendum: Nanostructured lipid carrier-mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases. Front Pharmacol. 2022;13:1002649. doi: 10.3389/fphar.2022.1002649, PMID: 36091766. (Front Pharmacol. 2021;12:713616). doi: 10.3389/fphar.2021.713616, PMID: 34616297.
36. Salman SS, Al-Ezzy RM, Soussi A. Green synthesis, analysis, and characterization of nano-silver-based Conyza canadensis (SYN: Erigeron canadensis) extract. Chem Methodol. 2024;8:856-73.
37. Abdullah MN, El Arbi M. Silver Nano loaded Solanum nigrum with potential biological activities. Chem Methodol. 2024;8(8):585-602. doi: 10.48309/chemm.2024.470323.1813
38. Ismail Ahmadi F, Fathollahi R, Dastan D. Phytochemical constituents and biological properties of Scutellaria condensata subsp. Pycnotricha. J Appl Organomet Chem. 2022;2(3):119-28. doi: 10.22034/ jaoc.2022.154719
39. Govindarajan R, Rastogi S, Vijayakumar M, Shirwaikar A, Rawat AK, Mehrotra S, et al. Studies on the antioxidant activities of Desmodium gangeticum. Biol Pharm Bull. 2003;26(10):1424-7. doi: 10.1248/ bpb.26.1424, PMID: 14519948
40. Pawbake GR, Shirolkar SV. Formulation, development and evaluation of nanostructured lipid carrier (NLC) based gel for topical delivery of diacerein. Syst Rev Pharm. 2020;11(6):794-802. doi: 10.31838/ srp.2020.6.116
41. Waghule T, Rapalli VK, Singhvi G, Manchanda P, Hans N, Dubey SK, et al. Voriconazole loaded nanostructured lipid carriers based topical delivery system: QbD based designing, characterization, in-vitro and ex-vivo evaluation. J Drug Deliv Sci Technol. 2019;52:303-15. doi: 10.1016/j.jddst.2019.04.026.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Madan Dadaso Pomaje, Shruti Shriram Tikam, Ashwini Bhauso Patil, Viraj Abhay Kamat

This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.